Aging Clinical and Experimental Research

, Volume 18, Issue 3, pp 257–260 | Cite as

Age-correlated decline in [3H]tiagabine binding to GAT-1 in human frontal cortex

  • Ingrid Sundman-Eriksson
  • Per AllardEmail author
Short Communication


Background and aims: In spite of the fact that GABA is a significant transmitter, little is known about the GABA system in aging, compared with other transmitter systems. [3H]tiagabine is a ligand for GABAergic neurons, which binds with 10-fold higher affinity to the GABA uptake site than [3H]nipecotic acid. The aim of this study was to study the binding of [3H]tiagabine to the GABA transporter 1, GAT-1, in human frontal cortex and cingulate cortex from individuals of varying ages. Methods: [3H]tiagabine binding experiments were conducted on post-mortem brain tissue from 19 individuals (age range 17–78 years) without known neurological or psychiatric disorders. Binding data vs age and postmortem interval was analysed by Pearson correlation. Results: The density of [3H]tiagabine binding to GAT-1 decreased significantly with increasing age in the frontal cortex, whereas binding affinity was unchanged. No significant alterations in binding parameters were observed in the cingulate cortex. No correlation was found between post-mortem delay and the number of [3H]tiagabine binding sites. Conclusions: According to the present study, presynaptical alterations in the GABA system are correlated with aging in the frontal cortex of the human brain. Further studies involving a broader range of brain regions seem warranted, to confirm the present findings and to enlarge knowledge about the GABA system in aging.

Key words

Aging GABA human brain [3H]tiagabine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ruano D, Araujo F, Bentareha R, Vitorica J. Age-related modifications on the GABAa receptor binding properties from Wistar rat prefrontal cortex. Brain Res 1996; 738: 103–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Araki T, Kato H, Fujiwara T, Itoyama Y. Regional age-related alterations in cholinergic and GABAergic receptors in the rat brain. Mech Ageing Dev 1996; 88: 49–60.PubMedCrossRefGoogle Scholar
  3. 3.
    Ishige K. Age-related changes in [3H]baclofen binding in mouse cerebellum. Gen Pharmacol 1995; 26: 1229–35.PubMedCrossRefGoogle Scholar
  4. 4.
    Cross JA, Cheetham SC, Crompton R, Katona CLE, Horton RW. Brain GABAb binding sites in depressed suicide victims. Psychiatry Res 1988; 26: 119–29.PubMedCrossRefGoogle Scholar
  5. 5.
    Suhara T, Inoue O, Kobayashi K, Suzuki K, Itoh T, Tateno Y. No age-related changes in human benzodiazepine receptor binding measured by PET with [11C]Ro 15-4513. Neurosci Lett 1993; 159: 207–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Sundman I, Allard P, Eriksson A, Marcusson J. GABA uptake sites in suicide victims and in normal aging. Neuropsychobiol 1997; 35: 11–5.CrossRefGoogle Scholar
  7. 7.
    Borden LA, Murali Dhar TG, Smith KE, Weinshank RL, Branchek TA, Gluchowski C. Tiagabine, SK&F 89976-A, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 1994; 269: 219–24.PubMedCrossRefGoogle Scholar
  8. 8.
    Durkin MM, Smith KE, Borden LA, Weinshank RL, Branchek TA, Gustafson EL. Localization of messenger RNAs encoding three GABA transporters in rat brain: an in situ hybridization study. Mol Brain Res 1995; 33: 7–21.PubMedCrossRefGoogle Scholar
  9. 9.
    Swan M, Najlerahim A, Watson RE, Bennett JP. Distribution of mRNA for the GABA transporter GAT-1 in the rat brain: Evidence that GABA uptake is not limited to presynaptic neurons. J Anat 1994; 185: 315–23.PubMedGoogle Scholar
  10. 10.
    Minelli A, Brecha NC, Karschin C, DeBiasi S, Conti F. GAT-1, a high affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J Neurosci 1995; 15: 7734–46.PubMedGoogle Scholar
  11. 11.
    Sundman Eriksson I, Allard P, Marcusson J. [3H]Tiagabine binding to GABA uptake sites in human brain. Brain Res 1999; 851: 183–8.CrossRefGoogle Scholar
  12. 12.
    Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107: 220–39.PubMedCrossRefGoogle Scholar
  13. 13.
    Andersson A, Sundman I, Marcusson J. Age stability of human brain 5-HT terminals studied with [3H]paroxetine binding. Gerontology 1992; 38: 127–32.PubMedCrossRefGoogle Scholar
  14. 14.
    Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res 1999; 620: 163–6.CrossRefGoogle Scholar
  15. 15.
    Tejani-Butt SM, Ordway GA. Effect of age on [3H]nisoxetine binding to uptake sites for norepinephrine in the locus coeruleus of hu- mans. Brain Res 1992; 583: 312–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Allard P, Marcusson JO. Age-correlated loss of dopamine uptake sites labeled with [3H]GBR-12935 in human putamen. Neurobi- ol Aging 1989; 10: 661–4.CrossRefGoogle Scholar
  17. 17.
    De Keyser J, Ebinger G, Vauquelin G. Age-related changes in the human nigrostriatal dopaminergic system. Ann Neurol 1990; 27: 157–61.PubMedCrossRefGoogle Scholar
  18. 18.
    Kemppainen N, Marjamaki P, Roytta M, Rinne JO. Different pat- tern of reduction of striatal dopamine reuptake sites in Alzheimer’s disease and ageing. J Neural Transm 2001; 108: 827–36.PubMedCrossRefGoogle Scholar
  19. 19.
    Zelnik NJ, Angel I, Paul SM, Kleinman JE. Decreased density of human striatal dopamine uptake sites with age. Eur J Pharmacol 1986; 126: 175–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Beach TG, Walker R, McGeer EG. Patterns of gliosis in Alzheimer’s disease. Glia 1989; 2: 420–36.PubMedCrossRefGoogle Scholar
  21. 21.
    Hansen LA, Armstrong DM, Terry RD. An immunohistochemi- cal quantification of fibrous atrocytes in the aging human cerebral cortex. Neurobiol Aging 1987; 8: 1–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Unger JW. Glial reaction in aging and Alzheimer’s disease. Mi- crosc Res Tech 1998; 43: 24–8.CrossRefGoogle Scholar
  23. 23.
    Liu X, Erikson C, Brun A. Cortical synaptic changes and gliosis in normal aging, Alzheimer’s disease and frontal lobe degeneration. Dementia 1996; 7: 128–34.PubMedGoogle Scholar
  24. 24.
    Sundman I, Lernmark U, Marcusson J. [3H]nipecotic acid binding to GABA uptake sites in human brain. Brain Res 1992; 580: 311–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Suzdak PD, Foged C, Andersen KE. Quantitative autoradiographic characterization of the binding of [3H]tiagabine (NNC 05328) to the GABA uptake carrier. Brain Res 1994; 647: 231–41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Internal Publishing Switzerland 2006

Authors and Affiliations

  1. 1.Department of Clinical Sciences, Division of PsychiatryUmeå UniversityUmeåSweden

Personalised recommendations